Posts Tagged ‘biederman’

US health agency revises conflict of interest rules

Tuesday, August 23rd, 2011

From Project on Government Oversight:

In recent years, Senator Grassley exposed several academic physicians for taking large amounts of money from companies with a direct financial interest in their research, some of it funded by the NIH. The list reads like a who’s who in academic research:

    • Dr. Charlie Nemeroff, former Chair of the Psychiatry Department at Emory University, who failed to report hundreds of thousands of dollars in payments from GlaxoSmithKline while researching that same company’s drugs with an NIH grant.  Dr. Nemeroff was bounced from Emory and has now taken over the Chair of Psychiatry at the University of Miami.
    • Dr. Alan Schatzberg, former Chair of the Psychiatry Department at Stanford University received an NIH grant to study a drug while partially owning a company that was seeking FDA approval of said drug. An NIH oversight group recommended that Stanford’s clinical trial on mifepristone be “terminated immediately and permanently.”  The recommendation was made because of concerns over conflicts of interest, patient safety and other issues.
    • Dr. Joseph Biederman and two other researchers at Harvard University failed to report almost a million dollars each in outside income while heading up several NIH grants. Harvard later disciplined the three physicians.

US health agency revises conflict of interest rules

From Reuters – August 23 – 2011

by  Alina Selyukh

WASHINGTON,  – The U.S. National Institutes of Health revised on Tuesday its 16-year-old conflict of interest rules for medical researchers, lowering the amount of money that constitutes a financial conflict and expanding the required disclosures.

The 1995 regulations effectively put responsibility for tracking scientists’ financial conflicts of interest on their universities. The rule required researchers to disclose conflicts to their institutions, which then had to assure the NIH the conflict had been managed, reduced or eliminated.

The new rule extends that requirement so researchers report not only the fact of a conflict of interest, but also its details such as value, specific nature, why it is a conflict and the impact it might have on research.

It lowers the amount a researcher must disclose if received from an industry or held in company stock to $5,000 from about $10,000.

Research institutions, in turn, are now required to report that information to the federal grant-awarding agency alongside details of how the conflicts are managed. Also, before spending any grant money, the institution has to post information about the financial conflicts on a public website.

The new rules will affect about 2,000 organizations that are awarded public health science funding every year and some 38,000 scientists who participate in research funded by these grants and have a “significant financial interest,” NIH said.

Concern about the integrity of research in the United States has grown since 2008, when Iowa Republican Sen. Charles Grassley criticized prominent Harvard University psychiatrist Dr. Joseph Biederman and others for failing to fully disclose payments from drug companies.

In a more recent example, medical device maker Medtronic Inc (MDT.N) came under fire over accusations that doctors paid by the company had failed to disclose major side effects from a bone growth drug in clinical trials.

A 2009 report by the Institute of Medicine, one of the National Academies of Sciences that advises U.S. policymakers, called on doctors to strictly disclose research funding to strengthen protection against conflicts of interest. The report called for virtually anyone involved in medicine — academic medical centers, journals, professional societies, researchers and doctors — to set up or strengthen conflict of interest guidelines.

From 1996 to 2007, relationships between individual academic researchers and industry nearly doubled, according to a study cited by NIH in its final rule. From 1994 to 2003, the amount of financial support for biomedical research almost tripled to $94.3 billion, with 57 percent of that funding coming from industry sources, according to analysis cited by NIH. (Additional reporting by Anna Yukhananov; editing by Andre Grenon)

http://www.reuters.com/article/2011/08/23/health-science-conflicts-idUSN1E77M1PB20110823

 

« Return to news items


Share

Children Exploited for Profit Using Fictitious Mental Disorders

Thursday, April 7th, 2011

"For over two decades drug and psychiatric industries have bombarded schools, parents, doctors, the media and government with propaganda that ADHD is a medical condition that must be managed with drugs."

NaturalNews.com— April 7, 2011

By Monica G. Young

We’re ashamed that exploitation of children for profit was once tolerated in America: such as children as young as five shackled to machines while working 16-hour days in factories, or black children auctioned and sold as slaves. Yet future generations will look back on our era too with shame: a time when labeling kids with fictitious mental disorders and hooking them on drugs was a multi-billion dollar business.

About 10 percent of U.S children – over five million – are said to have Attention Deficit Hyperactivity Disorder, a mental illness treated with drugs. A recent study blows a wide hole in that myth.

A team of Dutch researchers took 100 unmedicated children diagnosed with ADHD and fed half of them a diet free of processed foods and allergens. The other half served as a control group. Within five weeks, 64 percent of those in the test group saw remarkable changes. “After the diet, they were just normal children with normal behavior,” lead researcher Dr. Lidy Pelsser tells NPR. “They were no longer more easily distracted, they were no more forgetful, there were no more temper-tantrums.”

Dr. Pelsser explains, “ADHD, it’s just a couple of symptoms — it’s not a disease. There is a paradigm shift needed. If a child is diagnosed ADHD, we should say, ‘OK, we have got those symptoms, now let’s start looking for a cause.’… With all children, we should start with diet research. But now we are giving them all drugs, and I think that’s a huge mistake.”

Most ADHD-diagnosed kids are prescribed powerful stimulants which can cause nausea, insomnia, liver damage, heart failure, hallucinations, convulsions, violent behavior, suicidal thoughts and sudden death. The U.S. Drug Enforcement Administration categorizes these as Schedule II drugs – the same class as cocaine and opium.

For over two decades drug and psychiatric industries have bombarded schools, parents, doctors, the media and government with propaganda that ADHD is a medical condition that must be managed with drugs. But let’s dissect this:

* Pharmaceutical and psychiatric literature, ads and advocates typically claim ADHD kids have brain dysfunctions or brain chemical imbalances and that it’s genetically based, while also stating the cause is unknown and no lab tests can detect it.

Huh? As no lab tests can detect it and its cause is unknown, how can they scientifically link it to brain malfunction, chemical imbalances or genetic influence? They can’t.

* They say a doctor’s diagnosis relies on the child’s response to questions, the family’s description of behavior problems and a school assessment.

Hello? Can you imagine a doctor diagnosing cancer without lab tests? Or diagnosing diabetes and prescribing insulin injections based on a family member’s report? Or putting a boy’s leg in a cast due to a teacher’s assessment? We would call such a doctor a fraud.

* They say symptoms include impulsivity, dashing around, difficulty focusing on one thing, avoiding activities that are boring, squirming and bouncing a lot, talking excessively and finding it difficult to play quietly. And these symptoms must have been present before the age of seven.

Wait a second. When are kids generally the most spontaneous, energetic, rambunctious and have the lowest attention span? Before the age of seven!

* They say that in a child with ADHD, the above symptoms are more pronounced than in other kids the same age. In other words, this isn’t medical science – it’s OPINION. Plus they omit or enormously downplay the factor of diet.

*And here’s the clincher. They say ADHD cannot be cured but its symptoms can be managed with medication.

So there you have it – it’s clearly a marketing scheme to target children and create lifelong customers for the psychiatric drug industry.

Dr. Fred Baughman, neurologist and author who has testified before Congress, says it like this, “They made a list of the most common symptoms of emotional discomfiture of children; those which bother teachers and parents most, and in a stroke that could not be more devoid of science or Hippocratic motive — termed them a ‘disease.’ Twenty five years of research, not deserving of the term ‘research,’ has failed to validate ADD/ADHD as a disease. Tragically – the ‘epidemic’ having grown from 500 thousand in 1985 to between five and seven million today – this remains the state of the ‘science’ of ADHD.”

One of the world’s most influential child psychiatrists and “expert” proponents of ADHD for years has been Harvard’s Dr. Joseph Biederman. He has published hundreds of papers on ADHD and ADHD drug treatment, and is one of the most-cited researchers on the subject. In 2009 a Congressional inquiry revealed that between 2000-2007, Biederman earned at least $1.6 million in consulting fees from drug makers. It appears Dr. Biederman has an acute case of Greed Disorder.

Just as our country has defeated and outlawed child exploitation in the past, psychiatric labeling and drugging of children must too be abolished.

« Return to news items


Share

Grassley asks more mental health ‘patients rights’ groups (for ADHD, Bi-Polar, TeenScreen, etc.) to disclose Pharma $$

Tuesday, December 8th, 2009

For several years now, Senator Grassley has conducted extensive oversight and sought disclosure of financial ties with industry from research physicians, medical schools, medical journals, continuing medical education, and the patient advocacy community.   Now Senator Grassley has asked 33 medical groups for information about their financial backing they get from the medical device, insurance and pharmaceutical industries, including several psychiatric front groups such as Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD), Depression and Bipolar Support Alliance, Mental Health America, NARSAD, Screening for Mental Health Inc. and the National Center for Mental Checkups at Columbia University (TeenScreen).  Senator Grassley’s previous inquiry into the National Alliance on Mental Illness (NAMI) found that the majority of funding received was from the pharmaceutical industry; more than $28 million from pharmaceutical companies in the last four years.

In just the last two years, Grassley investigated and exposed extensive financial conflicts of interest of prominent psychiatrists with the pharmaceutical industry amounting to millions of dollars including Dr. Charles Nemeroff, Dr. Joseph Biederman, Dr. Melissa DelBello, Dr. Timothy Wilens, Dr. Thomas Spencer, Dr. Alan Schatzberg, Dr. Martin Keller, Dr. A. John Rush, Dr. Karen Wagner, Dr. Jeffrey Bostic and former head of the National Institute of Mental Health, Dr. Frederick Goodwin.  Additionally, Grassley investigated the American Psychiatric Association and the funding they received from the pharmaceutical industry.

For the latest inquiry from Senator Grassley read this article: http://www.iowapolitics.com/index.iml?Article=179090

« Return to news items


Share

Doctors shouldn’t work for drug companies; Promoting drugs for kids to make money is absolutely criminal

Tuesday, July 21st, 2009

The Alligator Editorial Board
The Independent Florida Alligator
July 21, 2009

Ritalin. Concerta. Vyvanse. Adderall. The Editorial Board is willing to bet that you know at least one person who has been prescribed one of them.

These drugs have been championed by well-known Harvard psychologist Joseph Biederman for decades. As a result, doctors have increasingly prescribed the medicines to those who may or may not need them.

Sen. Chuck Grassley, a Republican from Iowa, investigated Biederman’s drug company affiliations. It turns out Biederman worked as a private consultant for some drug companies, earning at least $1.6 million in the past seven years for his “advice,” according to The Boston Globe.

Grassley identified the conflict of interest that arises when the person who sets the precedent for how psychotropic drugs are dispensed is connected to drug companies. Both the companies and Biederman make bank as the drugs are dispersed.

Read entire article:  http://www.alligator.org/articles/2009/07/21/opinion/editorials/090721_eddy1.txt

« Return to news items


Share

Psychiatrist Joseph Biederman comes under fire for fueling child drugging epidemic while being funded by Pharma

Tuesday, July 21st, 2009

Paul Solomon
Digital Journal
July 18, 2009

Harvard child psychiatrist Joseph Biederman, whose work has helped fuel an explosion in the use of powerful antipsychotic drugs in children, has been caught up in controversy since a Congressional inquiry by Senator Charles Grassley (R-Iowa) in 2008.

Biederman has been criticized for being an advocate of diagnosing Attention Deficit Hyperactivity Disorder (ADHD) and bipolar disorder in even the youngest of children, and using antipsychotic medicines to treat them. Pharmaceutical companies are continuing to profit from the sale of these powerful and sometimes unnecessary drugs. The problem was that much of Biederman’s work was underwritten by drug makers for whom he was a private consultant. He was caught with his hand in the cookie jar.

The Congressional inquiry revealed last year that Biederman earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007, but failed to report all but $200,000 to Harvard officials. This constituted a major conflict of interest.

Read entire article:  http://www.digitaljournal.com/article/276135

« Return to news items


Share